Search

Record venture capital and heated deal environment propelled biotechnology industry forward in 2007, says Ernst & Young’s biotech report for last year.

The UK Technology Strategy Board has published its three-year strategic plan and outlined how it will promote and invest in technology-driven innovation.

The European Commission has launched a public consultation to inform a move to modernise and simplify the legislation on medical devices.

Europe’s politicians claim they are inching towards the Community Patent. But translation is still an issue and a single litigation area remains a distant hope.

Basic science remains of central importance, John Denham, UK Secretary of State for Innovation reassured the UK’s leading scientists in a speech last month.

Biotechnology and risk have always been synonymous. But now those risks are evolving and growing, exposing companies to fresh hazards.

Microsoft start-up programme Idées is going local in Lille – a prelude to going local globally.

Scientists and engineers from Germany, Belgium, the UK and the US scooped the top prizes in the European Innovator of the Year 2008 competition.

An exclusive focus on regulatory issues means we are ignoring a crucial longer-term question: the global competitiveness of the European ICT sector, says Martin Fransman.

Oxford University’s tech transfer company reports preliminary results for the year ending March 2008, with sales turnover up a third.

All research papers resulting from Irish Research Council funding must now be placed in an open access repository within six months of first publication.

UK pharmaceutical companies last year supported has nearly 14 per cent fewer PhD studentships and almost 25 per cent fewer postdoctoral grants than in 2003.

The UK government has announced the members of a board set up to provide it with strategic advice on intellectual property issues.